These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

763 related items for PubMed ID: 25476811

  • 1. GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.
    Atkinson P, Koch J, Ledger WL.
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):581-5. PubMed ID: 25476811
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C.
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [Abstract] [Full Text] [Related]

  • 4. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
    Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S.
    Fertil Steril; 2011 May; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The prevention of ovarian hyperstimulation syndrome.
    Corbett S, Shmorgun D, Claman P, REPRODUCTIVE ENDOCRINOLOGY INFERTILITY COMMITTEE, SPECIAL CONTRIBUTOR.
    J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
    [Abstract] [Full Text] [Related]

  • 10. GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at 'freeze-all strategy'.
    Ling LP, Phoon JW, Lau MS, Chan JK, Viardot-Foucault V, Tan TY, Nadarajah S, Tan HH.
    Reprod Biomed Online; 2014 Sep; 29(3):392-4. PubMed ID: 25042608
    [Abstract] [Full Text] [Related]

  • 11. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS, Joo BS, Moon SE, Lee SK, Kim KS, Koo JS.
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [Abstract] [Full Text] [Related]

  • 12. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
    Liang IT, Huang HY, Wu HM, Wang HS, Yu HT, Huang SY, Chang CL, Soong YK.
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
    [Abstract] [Full Text] [Related]

  • 13. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE, Beall SA, Cox JM, Richter KS, DeCherney AH, Levy MJ.
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.
    Bar-Hava I, Mizrachi Y, Karfunkel-Doron D, Omer Y, Sheena L, Carmon N, Ben-David G.
    Fertil Steril; 2016 Aug; 106(2):330-3. PubMed ID: 27114332
    [Abstract] [Full Text] [Related]

  • 16. Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support.
    Castillo JC, Dolz M, Bienvenido E, Abad L, Casañ EM, Bonilla-Musoles F.
    Reprod Biomed Online; 2010 Feb; 20(2):175-81. PubMed ID: 20113955
    [Abstract] [Full Text] [Related]

  • 17. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R, Nahum R, Zohav E, Liberty G, Anteby EY, Meltcer S.
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [Abstract] [Full Text] [Related]

  • 18. GnRH agonist-only trigger, compared to dual trigger, reduces oocyte retrieval rate in high responders without affecting cumulative live birth rate.
    Wang Y, Yi YC, Guu HF, Chen YF, Kung HF, Chang JC, Chen LY, Chuan ST, Chen MJ.
    Front Endocrinol (Lausanne); 2024 Jan; 15():1461317. PubMed ID: 39229374
    [Abstract] [Full Text] [Related]

  • 19. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY.
    Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.